VHL
Showing 1 - 25 of 91
VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer
Recruiting
- VHL Pancreatic Neuroendocrine Tumors
- +2 more
- 68-Gallium DOTATATE
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
VHL - Von Hippel-Lindau Syndrome, VHL Gene Mutation, VHL Syndrome Trial in Worldwide (Belzutifan)
Active, not recruiting
- VHL - Von Hippel-Lindau Syndrome
- +5 more
-
Bethesda, Maryland
- +10 more
Aug 16, 2022
Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)
Available
- Clear Cell Kidney Cancer
- +2 more
- Axitinib 5 MG
- (no location specified)
Jul 3, 2023
Von Hippel-Lindau Disease, Genetic Disorder Trial in Boston (3RP-VHL)
Not yet recruiting
- Von Hippel-Lindau Disease
- Genetic Disorder
- 3RP-VHL
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Feb 10, 2023
Von Hippel-Lindau: Clinical Manifestations, Diagnosis,
Recruiting
- Kidney Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Brain and Spinal Cord Tumor Growth and Cyst Development in Von
Active, not recruiting
- Hemangioblastoma
- Hippel Lindau Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Von Hippel-Lindau Disease, Hereditary Leiomyomatosis and Renal Cell Cancer, Birt-Hogg-Dube Syndrome Trial in Boston
Recruiting
- Von Hippel-Lindau Disease
- +3 more
-
Boston, MassachusettsVHL Alliance
Oct 4, 2021
Frequency, Clinical Phenotype and Genetic Analysis of Heritable
Not yet recruiting
- Renal Tumor Histology
- +13 more
- Gene test
-
Shanghai, Shanghai, ChinaEthics Committee of Shanghai Renji Hospital
Sep 6, 2022
Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease Trial in Worldwide (Belzutifan)
Recruiting
- Pheochromocytoma/Paraganglioma
- +2 more
-
Los Angeles, California
- +58 more
Jan 27, 2023
Patients With Von Hippel Lindau Disease
Not yet recruiting
- Von Hippel Lindau Disease
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2023
Von Hippel-Lindau Disease Trial (68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and
Not yet recruiting
- Von Hippel-Lindau Disease
- 68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and pelvis) 68Ga-NODAGA-LM3 PET/CT (exploratory)
- (no location specified)
Mar 30, 2023
Von Hippel-Lindau Disease Genetic Epidemiology Study
Terminated
- Von Hippel Lindau Disease
- Kidney Neoplasms
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 9, 2020
Hemangioblastoma of CNS, Von Hippel-Lindau Disease Trial in Le Kremlin Bicêtre (Propranolol, follow-up)
Not yet recruiting
- Hemangioblastoma of CNS
- Von Hippel-Lindau Disease
- Propranolol
- follow-up
-
Le Kremlin Bicêtre, FranceAP-HP, Bicêtre Hospital
Jun 14, 2022
Von Hippel-Lindau Syndrome Trial run by the NEI (Ranibizumab, E10030)
Completed
- Von Hippel-Lindau Syndrome
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 21, 2021
Metastatic Renal Cell Carcinoma, Fumarate Hydratase Deficient Renal Cell Carcinoma, Succinate Dehydrogenase Deficient Renal Cell
Recruiting
- Metastatic Renal Cell Carcinoma
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Dec 21, 2021
Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma Trial in Rochester
Completed
- Malignant Adrenal Gland Pheochromocytoma
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Rochester, MinnesotaMayo Clinic
Sep 28, 2022
Pancreatic Cyst, Molecular, Chemical Analysis of Cystic Fluid Trial in Seoul
Recruiting
- Pancreatic Cyst
- Molecular, Chemical Analysis of Cystic Fluid
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 10, 2022
Neuroendocrine Neoplasms Including Adrenocortical Carcinoma
Recruiting
- Neuroendocrine Tumors
- Carcinoma, Neuroendocrine
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Ischemic Heart Disease Trial in Rome (OCT)
Not yet recruiting
- Ischemic Heart Disease
- OCT
-
Rome, ItalyPoliclinico A. Gemelli. Università Cattolica del Sacro Cuore
Oct 16, 2022
Hereditary Leiomyomatosis Renal Cell Cancer - Study of Genetic
Recruiting
- Renal Tumor Histology
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 28, 2022
Early Development of Endometrial Carcinoma
Recruiting
- Cancer of Endometrium
-
Ferrara, ItalySection of Obstetrics and Gynecology, Department of Morphology,
Apr 4, 2022
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)
Recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Olaparib
- +13 more
-
Edmonton, Alberta, Canada
- +9 more
Jan 9, 2023
Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma of the Hypopharynx, Metastatic Squamous
Active, not recruiting
- Metastatic Head and Neck Squamous Cell Carcinoma
- +9 more
- Carboplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 27, 2022